We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
PRM.LSE

Price
3.21
Stock movement up
+0.20 (6.64%)
Company name
Proteome Sciences PLC
Exchange
(LSE
,
Currency
GBX
)
Sector
Healthcare >
Diagnostics & Research
Market cap
947.53M
Ent value
961.05M
Price/Sales
0.04
Price/Book
-
Div yield
-
Div growth
-
Growth years
-
FCF payout
50.89%
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-
1 year return
-2.73%
3 year return
-5.88%
5 year return
-2.27%
10 year return
-22.30%
Last updated: 2025-04-12

DIVIDENDS

PRM.LSE does not pay dividends or no data was received

VALUATION

Valuation Ratios

Valuation Ratios data
Trailing P/E-
Price to OCF0.16
Price to FCF0.22
Price to EBITDA0.14
EV to EBITDA0.14

Valuation (Sales/Book Value)

Valuation (Sales/Book Value) data
Price to Sales0.04
Price to Book-
EV to Sales0.04

FINANCIALS

Per share

Per share data
Current share count295.18M
EPS (TTM)-0.02
FCF per share (TTM)14.61

Income statement

Income statement data
Revenue (TTM)23.50B
Gross profit (TTM)23.49B
Operating income (TTM)7.42B
Net income (TTM)-4.66M
EPS (TTM)-0.02
EPS (1y forward)-

Margins

Margins data
Gross margin (TTM)99.98%
Operating margin (TTM)31.56%
Profit margin (TTM)-0.02%

Balance Sheet

Please create a free account or log in to access this chart
Balance Sheet data
Cash1.21M
Net receivables627.00K
Total current assets2.61M
Goodwill4.22M
Intangible assets0.00
Property, plant and equipment0.00
Total assets9.45M
Accounts payable675.00K
Short/Current long term debt13.62M
Total current liabilities13.22M
Total liabilities14.72M
Shareholder's equity-5.27M
Net tangible assets0.00

Cash flow

Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)6.03B
Capital expenditures (TTM)1.72B
Free cash flow (TTM)4.31B
Dividends paid (TTM)2.19B

Financial returns

Please create a free account or log in to access this chart
Financial returns data
Return on Equity-
Return on Assets-49.25%
Return on Invested Capital-63.94%
Cash Return on Invested Capital59226.81%

STOCK INFORMATION

Stock chart

Stock price data
Open3.16
Daily high3.38
Daily low2.93
Daily Volume145K
All-time high235.43
1y analyst estimate6.00
Beta0.13
EPS (TTM)-0.02
Dividend per share-
Ex-div date-
Next earnings date-

Downside potential

Downside potential data
PRM.LSES&P500
Current price drop from All-time high-98.64%-12.89%
Highest price drop-99.04%-56.47%
Date of highest drop20 Dec 20189 Mar 2009
Avg drop from high-81.73%-11.07%
Avg time to new high363 days12 days
Max time to new high5217 days1805 days
COMPANY DETAILS
PRM.LSE (Proteome Sciences PLC) company logo
Marketcap
947.53M
Marketcap category
Small-cap
Description
Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids. It also provides top 14 and top 65 super depletion of proteins from serum and plasma; selective reaction monitoring (SRM) and parallel reaction monitoring (PRM) based biomarker assay development; SRM assay, a targeted mass spectrometry assay format for the routine measurement of biomarkers; and TMT SRM, a targeted assay format that enables the rapid validation of biomarker candidates. The company serves its products to pharmaceutical and biotechnology companies, and academic research institutes. The company was incorporated in 1993 and is based in Cobham, the United Kingdom.
Employees
35
Website
https://www.proteomics.com
Investor relations
-
SEC filings
PRM.LSE SEC filings
CEO
Country
UK
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
UNDERSTAND THE BUSINESS
COMPANY NEWS
All newsPress releases
No items found
Disclaimer
Skyfall Technology OÜ assumes no responsibility or liability for any errors or omissions in the content of this site. The information contained in this site is provided on an “as is” basis with no guarantees of completeness, accuracy, usefulness or timeliness. Please also note, that any action you take upon the information provided on this website is strictly at your own risk. This website is intended to be used and must be used for informational purposes only and you should take independent financial advice from a professional and independently research and verify everything you see on the site.
Menu
HomePortfolio ManagementCompany ScreenerGreen InvestmentExchangesContact Us
Language
ENHUNOSVDAFIESDENLFRITPTPLCSSKROELTRRUAF
© 2024 Skyfall Technology OÜ All Rights Reserved